筋膜下原发性隆乳联合脂肪移植:156例回顾性综述
该研究回顾性分析了2007至2013年间156例接受假体联合脂肪移植进行原发性隆乳的患者,平均随访22.25个月。总并发症率为7.7%,再手术率为9.94%,最常见并发症为Baker II/III级包膜挛缩。作者认为复合隆乳是一种有价值、稳定、可靠的技术,可获得自然外观的长期美学效果,并避免肌肉下平面。
要点
- 复合隆乳(假体+脂肪移植)总并发症率7.7%,再手术率9.94%。
- 最常见并发症为Baker II/III级包膜挛缩,其次为感染、血肿和假体旋转。
- 平均注射脂肪126 cc(范围30-250 cc),平均假体大小252 cc。
核心结论
- 复合隆乳是乳房美容外科中一种有价值、稳定、可靠的技术,可获得自然外观的长期美学效果,并避免肌肉下平面。
研究设计与样本
- 回顾性病历审查,纳入2007至2013年间接受假体联合脂肪移植进行原发性隆乳的所有患者,共156例。
主要发现
- 平均患者年龄31.7岁,平均体重指数18.85 kg/m,平均假体大小252 cc,平均注射脂肪126 cc(范围30-250 cc)于皮下软组织。
- 平均随访22.25个月(范围1-86个月),总并发症率7.7%,再手术率9.94%。
- 最常见并发症为Baker II/III级包膜挛缩(Baker II级n=4,2.56%;Baker III级n=2,2%),其次为感染(n=2,1.28%)、血肿(n=2,1.28%)和假体旋转(n=1,0.64%)。
- 9例(9.94%)行延迟再手术,平均间隔31.7个月;2例Baker III级包膜挛缩需手术矫正;3例(1.92%)因软组织覆盖不足需额外脂肪移植,平均再注射脂肪量170 cc。
临床怎么用
- 复合隆乳可用于原发性乳房增大,尤其适合希望避免肌肉下平面并获得自然外观的患者。
- 需告知患者总并发症率约7.7%、再手术率约9.94%,包膜挛缩是最常见并发症。
局限性
- 回顾性研究,证据等级为治疗性IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Composite breast augmentation with fat grafting and an implant has become very popular in the past 5 years. This achieves the core volume projection of an implant complemented by the natural appearance and feel of fat. However, no study has looked at the complications and reoperation rates of this technique. METHODS: A retrospective chart review examined all patients who underwent the combined use of an implant and fat grafting for primary breast augmentation. RESULTS: The study identified 156 patients between 2007 and 2013. The mean patient age was 31.7 years and the average body mass index was 18.85 kg/m. The average implant size was 252 cc. Patients received a mean of 126 cc of fat (range, 30 to 250 cc) in subcutaneous soft tissue. Follow-up averaged 22.25 months (range, 1 to 86 months). The total complication rate was 7.7 percent and the reoperation rate was 9.94 percent. Baker grade II/III contracture was the most common complication [Baker grade II, n = 4 (2.56 percent); Baker grade III, n = 2 (2 percent)], followed by infections [n = 2 (1.28 percent)], hematoma [n = 2 (1.28 percent)], and malrotation [n = 1 (0.64 percent)]. Delayed reoperation was performed in nine patients (9.94 percent) after a mean interval of 31.7 months. Two patients who developed Baker grade III contractures needed surgery to correct the problem. Three cases (1.92 percent) required additional fat grafting for insufficient soft-tissue coverage. The mean volume of fat reinjection was 170 cc. CONCLUSIONS: Composite breast augmentation is a valuable, stable, reliable technique in breast aesthetic surgery with good, natural-appearing results. It provides long-term aesthetic benefits and avoids the submuscular plane. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Kerfant N, Henry AS, Hu W, et al. Subfascial Primary Breast Augmentation with Fat Grafting: A Review of 156 Cases. Plast Reconstr Surg. 2017. PMID: 28445355. doi:10.1097/PRS.0000000000003299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。